Medications
When it comes to treating disruptive mood dysregulation disorder, there are currently no medications approved by the U.S. Food and Drug Administration specifically for this condition. However, healthcare professionals often turn to stimulants, antidepressants, and atypical antipsychotics as alternative options to alleviate the symptoms. It is important to note that atypical antipsychotics can potentially lead to severe side effects. Therefore, doctors only resort to prescribing them when other treatment methods have proven ineffective. As for antidepressants, it is crucial to be cautious, especially when prescribing them to young individuals, as they may heighten the risk of suicidal thoughts and behaviors. Consequently, caregivers and doctors closely monitor children who are prescribed these medications.
Epidemiology
Understanding the prevalence of disruptive mood dysregulation disorder (DMDD) is challenging due to limited research. However, current primary studies indicate that the rate of DMDD falls within the range of 0.8% to slightly above 3%. It is worth noting that approximately 3% of children experience persistent problems with anger and irritability, but it remains uncertain if all of these cases can be classified as DMDD.